Teicoplanin Dosing Regimen

General Dosing Guidelines

• The standard treatment of infections should be administered with a loading dose of 6 mg/kg (or 12 mg/kg for severe infections) three times at 12-hour intervals, followed by a maintenance dose of 6 mg/kg (or 12 mg/kg for severe infections) once daily, with dose adjustments based on renal function 1, 2, 3, 4
• Initial loading dose is 6 mg/kg every 12 hours for three doses 1, 3, 4
• Higher loading dose for severe infections is 12 mg/kg every 12 hours for three doses (S. aureus endocarditis or septic arthritis) 1, 3
• Maintenance dose is 6 mg/kg once daily (standard infections) 1, 3
• Higher maintenance dose for severe infections is 12 mg/kg once daily (S. aureus endocarditis or septic arthritis) 1, 3

Dose Adjustment Based on Renal Function

• For normal renal function (GFR > 90 mL/min), the dose should be administered every 24 hours 1, 3
• For moderate renal impairment (GFR 50-90 mL/min), the dose should be administered every 24 hours 1, 3
• For severe renal impairment (GFR 10-50 mL/min), the dose should be administered every 48 hours 1, 3
• For end-stage renal disease (GFR < 10 mL/min), the dose should be administered every 72 hours 1, 3

Special Clinical Situations

• For hemodialysis patients, a loading dose of 12 mg/kg should be administered, followed by 6 mg/kg on days 2 and 3, and maintenance of 6 mg/kg once weekly 1, 3
• For CAPD peritonitis, IV dosing should follow GFR < 10 mL/min recommendations, and intraperitoneal dosing should be 20 mg/L in each bag for the first week, 20 mg/kg every other bag for the second week, and 20 mg/kg in the night bag only for the third week 1, 3
• For continuous renal replacement therapy, dosing should follow GFR 10-50 mL/min recommendations 1, 3
• For pediatric patients, loading dose is three doses of 10 mg/kg every 12 hours, and maintenance dose is 6-10 mg/kg every 24 hours 1, 3

Therapeutic Drug Monitoring

• Routine monitoring is not generally recommended by manufacturers, but is indicated in specific situations such as S. aureus endocarditis or septic arthritis (target trough ≥ 20 mg/L), patients with major burns, intravenous drug users, and rapidly changing renal function 1, 3

Infection-Specific Recommendations

• For complicated skin and soft tissue infections, adults should receive 6-12 mg/kg IV q12h for three doses, then once daily, for a duration of 7-14 days 5, 6, 7
• For bacteremia, uncomplicated cases should receive 6-12 mg/kg IV q12h for three doses, then once daily, for a duration of 2 weeks, while complicated cases should receive 6-12 mg/kg IV q12h for three to six doses, then 6-12 mg/kg once daily, for a duration of 4-6 weeks 5, 6, 7
• For osteomyelitis and septic arthritis, patients should receive 6-12 mg/kg IV q12h for three doses, then once daily, for a duration of >6 weeks for osteomyelitis and 3-4 weeks for septic arthritis 5, 6, 7, 8

Teicoplanin Dosing Recommendations for Severe Infections

Infection-Specific Dosing

• For Fournier's gangrene, a loading dose of 12 mg/kg every 12 hours for 3 doses, then 6 mg/kg every 12 hours as part of combination therapy is recommended, according to the World Journal of Emergency Surgery 9

Special Considerations

• No other facts were found with associated citations.

Teicoplanin Treatment Guidelines

Duration by Infection Type

• The duration of teicoplanin therapy for uncomplicated skin infections is 5-10 days, as recommended by the Infectious Diseases Society of America 10
• For complicated inpatient skin and soft tissue infections, the treatment duration is 7-14 days 10
• Uncomplicated bacteremia requires 2 weeks of teicoplanin therapy, defined as bacteremia with negative follow-up blood cultures within 2-4 days, no implanted prosthetic devices, no evidence of endocarditis, and defervescence within 72 hours 10
• Complicated bacteremia requires 4-6 weeks of treatment, including any bacteremia not meeting criteria for uncomplicated disease 10
• Hospital-acquired or ventilator-associated pneumonia treatment duration is 7-21 days, depending on clinical response and pathogen 10
• Native valve endocarditis requires 4-6 weeks of teicoplanin therapy 10
• Prosthetic valve endocarditis requires 6 weeks of treatment in combination with rifampin and gentamicin 10
• Osteomyelitis treatment duration is more than 6 weeks 10
• Meningitis requires 14 days of teicoplanin therapy 10
• Brain abscess, subdural empyema, and spinal epidural abscess require 4-6 weeks of treatment 10

Critical Dosing Considerations That Impact Duration

• The standard loading regimen for teicoplanin is 6 mg/kg IV every 12 hours for three doses, followed by maintenance dosing of 6 mg/kg once daily, as recommended by the American Society of Health-System Pharmacists 10

Common Pitfalls to Avoid

• Complicated bacteremia requires 4-6 weeks of treatment to prevent relapse and metastatic infection, and standard 2-week courses should not be used 10
• Parenteral therapy should be maintained throughout the treatment course for complicated bacteremia, and transition to oral therapy should not be done prematurely 10
• Therapy should not be stopped based solely on symptom resolution, and the full duration based on infection type should be completed to prevent relapse 10

Teicoplanin Dosing and Monitoring for Serious Gram‑Positive Infections

Loading Dose Recommendations

Maintenance Dosing by Renal Function

Special Populations

Hemodialysis Patients

Continuous Renal Replacement Therapy (CAVH/CVVH)

CAPD Peritonitis

Therapeutic Drug Monitoring

Treatment Duration

Combination Therapy for Prosthetic Valve Endocarditis

Teicoplanin Dosing Recommendations for Serious Gram‑Positive Infections

Loading Dose Regimens

• For standard Gram‑positive infections in adults, give a loading dose of 6 mg/kg intravenously every 12 h for three doses 13.
• For severe infections (e.g., endocarditis, septic arthritis, complicated bacteremia) in adults, give a loading dose of 12 mg/kg intravenously every 12 h for three doses 13.
• In patients undergoing hemodialysis, the loading dose remains 12 mg/kg intravenously 13.

Maintenance Dose Regimens

• For standard infections in adults with normal renal function, administer 6 mg/kg intravenously once daily 13.
• For severe infections in adults with normal renal function, administer 12 mg/kg intravenously once daily 13.
• The loading dose is unchanged regardless of renal function; only the maintenance interval is adjusted based on glomerular filtration rate (GFR) 13.

Renal Function‑Based Interval Adjustments

These interval recommendations apply to both standard and severe infection maintenance doses 13.

Special Clinical Situations

• Hemodialysis: After the 12 mg/kg loading dose, give 6 mg/kg on days 2 and 3, then 6 mg/kg once weekly for maintenance 13.
• Continuous renal replacement therapy (CAVH/CVVH): Follow the GFR 10–50 mL/min schedule (maintenance every 48 h) 13.
• CAPD peritonitis – intravenous route: Use the GFR < 10 mL/min schedule (maintenance every 72 h) 13.
• CAPD peritonitis – intraperitoneal route: In week 2, give 20 mg/kg every other dialysis bag 13.

Therapeutic Drug Monitoring (TDM)

• For severe infections, target a trough concentration ≥ 20 mg/L 13.
• Routine TDM is not recommended for standard infections, but is mandatory in:
• Monitoring frequency: Check trough levels on day 4 after the loading doses, repeat at steady state (≈ day 7–11), and continue twice weekly throughout therapy 13.

Key Pitfalls

• Do not omit loading doses in any renal function category; failure to give an adequate loading dose leads to sub‑therapeutic levels in the first week 13.
• Do not reduce loading doses in renal impairment; only adjust the maintenance interval as outlined above 13.